There have been great strides made recently in treating the most difficult and debilitating health conditions people face. Yet, there is still much work to be done if we are going to find truly effective therapies for these conditions. At Pfizer, we work to make our drug development process more efficient by collaborating with unique partners and exploring new pathways that harness technology and emerging science. At the core of this work is the belief that collaboration – across organizations, industries and even therapeutic areas – is essential to driving measurable progress and revolutionizing care. These efforts include:
· Leading a transformative approach to Precision Medicine
· Connecting with Parkinson’s disease patients to improve therapies
· Blazing the trail in gene therapy
Learn more about how Pfizer is using transformative science to accelerate patient care: www.pfizer.com/annual.
KEYWORDS: Innovation & Technology, Health & Healthcare, Pfizer, Partnerships, annual review, access, medicines, Corporate Social Responsibility